Answers are grounded in this paper and cite their sources.
The triazole drug fluconazole remains one of the most commonly prescribed antifungal drugs, both for prophylaxis in high-risk patients and also as a second-line treatment option for invasive Candida infections. Established susceptibility profiles and clinical interpretive breakpoints are available for fluconazole with Candida albicans , Candida glabrata , Candida tropicalis , and Candida parapsilosis , which account for the majority of infections due to pathogenic yeast species.
No takes yet. Share an insight, caveat, or question.
Borman et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: